BioSpace News Archive

Business

MDimune pens FAF1 mRNA cancer drug deal with Kainos Medicine

MDimune Inc. and Kainos Medicine, Inc., has inked a collaboration pact and possible licensing deal with MDimune Inc. for disruptive cancer therapy development based on cell-derived vesicles (CDVs) like extracellular vesicles (EVs) loaded with Fas-associated Factor 1 (FAF1) expressing mRNA or protein.

October 29, 2021
·
2 min read
Pharm Country

High Availability of Fast-Food Restaurants Across All U.S. Neighborhood Types Linked to Higher Rates of Type 2 Diabetes, New Study Finds

An increasing number of studies suggest a link between a neighborhood’s built environment and the likelihood that its residents will develop chronic diseases such as heart disease, type 2 diabetes and certain types of cancers.

October 29, 2021
·
4 min read
Business

Result of AGM

MaxCyte, Inc. announces that at its Annual General Meeting held on 29th October 2021, all resolutions were duly passed, with the exception of Proposal 2, relating to the approval of the 2021 Equity Incentive Plan.

October 29, 2021
·
1 min read
Policy

FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age

The U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age.

October 29, 2021
·
7 min read
Pharm Country

BioAegis Therapeutics to Present “Conquering Pneumonia and Systemic Inflammation with a Human Protein,” at the MACRO Trends Investor Conference in Belgium

BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious, inflammatory, and degenerative diseases based on a portfolio built around gelsolin technology, announces that it was selected to present at the MACRO Trends Investor Conference on November 12, 2021.

October 29, 2021
·
3 min read
Business

Kiniksa Pharmaceuticals to Report Third Quarter 2021 Financial Results on November 1, 2021

Kiniksa Pharmaceuticals, Ltd. announced that it will host a conference call and live webcast on Monday, November 1, 2021, at 8:30 a.m. Eastern Time to report its third quarter 2021 financial results and recent portfolio execution.

October 29, 2021
·
1 min read
BioMidwest

U.S. Food and Drug Administration Approves VUITY™ (pilocarpine HCI ophthalmic solution) 1.25%, the First and Only Eye Drop to Treat Presbyopia (Age-Related Blurry Near Vision)

Allergan, an AbbVie company, announced the U.S. Food and Drug Administration approval of VUITY™ 1.25% for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults.

October 29, 2021
·
7 min read
Business

Biogen Canada Welcomes Eric Tse as New General Manager in New Toronto Head Office

Biogen Canada Inc. is pleased to announce Eric Tse has been named as its new General Manager, responsible for leading the company’s operations in Canada.

October 29, 2021
·
4 min read
Business

Baylor and Harvard Researchers Partner in Long-Term, Global Study of Human Flourishing

Researchers at Harvard University and Baylor University launch the largest initiative of its kind to investigate the determinants of human flourishing.

October 29, 2021
·
7 min read
Business

SOC Telemed to Provide Corporate and Financial Update for the Third Quarter 2021 on November 12, 2021

SOC Telemed, Inc. today announced that the company will provide a corporate and financial update for the third quarter 2021, on Friday, November 12, 2021, before market open.

October 29, 2021
·
2 min read